Insulin (long-acting)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Insulin (long-acting), covering 2010-11-25 to 2010-11-25. Get the full timeline:
Most recent: Clinical Trial Update: The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes [Phase 4]